Genoa Ventures, LLC
Emerging managerSEC exempt reporting adviser (venture capital exemption).
- Website
- https://www.genoavc.com/
- HQ
- CA
Genoa Ventures invests at the intersection of biology and technology, aiming to identify opportunities early and back companies that defy categories. Its portfolio includes HydRegen, Aqtual, and Hermes Biosciences. The firm also has a partner, Jenny Rooke, who has spoken at industry events.
01 · Says / Does
| Tag | Says | Does | Historically (to 2020) |
|---|---|---|---|
| Stages | Not stated | Not enough dated deals | Series A, Seed, Series B |
| Sectors | Not stated | Not enough dated deals | Biotech, Healthtech, Life sciences and research tools, Medical devices, AI applications, Hardware |
| Regions | Not stated | Not enough dated deals | CA |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
Historical focus (through 2020), derived from historical deal data.
| Year | Deals | Top sectors |
|---|---|---|
| 2007 | 1 | Biotech, Healthtech, Manufacturing |
| 2009 | 1 | Biotech, Manufacturing, Medical devices |
| 2011 | 1 | Advanced materials, Biotech |
| 2013 | 1 | Biotech, Medical devices |
| 2014 | 3 | AI applications, Hardware, Biotech |
| 2015 | 3 | Healthtech, AI applications, Biotech |
| 2016 | 2 | Biotech, Agtech, Healthtech |
| 2017 | 5 | Biotech, Healthtech, Medical devices |
| 2018 | 3 | Biotech, Healthtech, Life sciences and research tools |
| 2020 | 2 | Biotech, Agtech |
Stage mix over time
- Pre-seed
- Seed
- Series A
- Series B
- Growth
| Year | Pre-seed | Seed | Series A | Series B | Growth |
|---|---|---|---|---|---|
| 2013 | 0 | 0 | 0 | 1 | 0 |
| 2014 | 0 | 2 | 1 | 0 | 0 |
| 2015 | 0 | 1 | 2 | 0 | 0 |
| 2016 | 0 | 0 | 1 | 1 | 0 |
| 2017 | 0 | 2 | 0 | 1 | 1 |
| 2018 | 0 | 0 | 2 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 2 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 0 | 0 |
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Genoa Ventures Fund III, LP | approx. 2024 | Not reported | Open, writing first checks |
| Genoa Ventures Fund II-A, LP | approx. 2021 | $1.2M (SEC adviser filing) | Late investment period |
| Genoa Ventures Fund II, LP | 2021 | $56.68M to $77.86M (Form D and SEC adviser filing) | Follow-ons only |
03 · People across funds
- Jenny Rooke, Member of the General Partner of the Issuer
Genoa Ventures Fund III, LP (Named on Form D); Genoa Ventures Fund II-A, LP (Named on Form D); Genoa Ventures Fund II, LP (Named on Form D)
- Vikram Chaudhery
On the team page, not linked to a fund
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 25, 2026